Madrigal Pharmaceuticals Inc (MDGL)
Sales/Maturities of Investments
$1.06B
TTM · Period ending: · USD
MDGL Sales/Maturities of Investments
Latest reported$1.06Bperiod ending
Latest reported$1.06Bperiod ending
MDGL TTM Sales/Maturities of Investments ($28.15M → $1.06B)
TTM Sales/Maturities of Investments
High-resolution chart · PNG
MDGL sales/maturities of investments history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Sales/Maturities of Investments (USD) |
|---|---|
| 1,059,287,000 | |
| 1,142,476,000 | |
| 1,083,297,000 | |
| 1,145,582,000 | |
| 1,084,934,000 | |
| 975,366,000 | |
| 863,283,000 | |
| 674,655,000 | |
| 579,625,000 | |
| 504,012,000 | |
| 333,398,000 | |
| 298,796,000 | |
| 258,772,000 | |
| 268,829,000 | |
| 350,381,000 | |
| 341,685,000 | |
| 417,759,000 | |
| 422,517,000 | |
| 389,274,000 | |
| 430,137,000 | |
| 428,769,000 | |
| 440,337,000 | |
| 489,456,000 | |
| 559,945,000 | |
| 575,094,000 | |
| 589,216,000 | |
| 650,182,000 | |
| 582,744,000 | |
| 464,573,000 | |
| 384,620,000 | |
| 234,304,000 | |
| 161,271,000 | |
| 97,131,000 | |
| 56,838,000 | |
| 48,330,000 | |
| 24,428,000 | |
| 5,270,846 | |
| 6,025,846 | |
| 26,062,846 | |
| 44,337,846 | |
| 113,770,000 | |
| 131,793,000 | |
| 137,193,000 | |
| 125,898,000 | |
| 103,962,000 | |
| 102,384,000 | |
| 85,152,000 | |
| 88,588,000 | |
| 91,746,000 | |
| 91,085,000 | |
| 90,267,000 | |
| 73,117,000 | |
| 71,209,000 | |
| 49,895,000 | |
| 40,595,000 | |
| 53,946,000 | |
| 51,748,000 | |
| 59,053,000 | |
| 60,745,000 | |
| 53,894,000 | |
| 39,592,000 | |
| 28,592,000 | |
| 17,250,000 | |
| 16,940,000 | |
| 38,193,000 | |
| 58,197,000 | |
| 60,806,000 | |
| 43,866,000 | |
| 22,613,000 | |
| 2,609,000 | |
| 0 | |
| 0 | |
| 0 | |
| 1,000,000 | |
| 28,149,000 | |
| 56,883,000 | |
| 112,711,000 |